Search Results 301-310 of 17145 for nivolumab
The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...
... nivolumab in each disease cohort, both across and within tumor biomarker subgroups. Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line ...
... nivolumab for mesothelioma, and others. Dr. Mansfield's research has been supported by multiple organizations, including the National Cancer Institute, the ...
This randomized phase II/III trial studies how well azacitidine with or without nivolumab or midostaurin, or decitabine and cytarabine alone work in treating ...
... nivolumab as combination therapy, and to establish the dose of TP-1454 recommended to be used alone and in combination with ipilimumab and nivolumab in ...
... nivolumab, pembrolizumab, atezolizumab, OX40 agonists, 4-1BB agonists). Exclusion Criteria: A history of treatment including any of the following: Prior ...
Lachance is a CERN participant, the Mayo Clinic PI for A Randomized Study of Nivolumab Versus Bevacizumab and a Safety Study of Nivolumab or Nivolumab ...
... Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report. J Blood Med. 2024; 15:29-34 Epub 2024 Jan 24. View PubMed; Kettani ME, Shah K, Farooq H, Li ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!